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Abstract
Background: Lipid-enriched diets and oxidative stress are risk factors for the development of atherosclerosis. The
effects of the methanolic (ME) and cyclohexane (CHE) extracts of the Pistacia vera nut, often included in the
Mediterranean diet, were studied in the rabbit model of atherosclerosis.
Methods and results: Twenty-four New Zealand White rabbits received atherogenic diet (Control Group),
supplemented with ME (Group ME) or CHE (Group CHE) for 3 months. Previously, a GC-MS and a UHPLC LC-DAD-
ESI(-)-HRMS/MS method were developed to investigate the extracts’ chemical profiles. Blood samples at baseline
and monthly determined lipid profile, lipid peroxidation and liver function. The aorta, myocardium and liver were
examined histologically at 3 months.
Groups ME and CHE had significantly higher HDL- and non-significantly lower LDL-cholesterol median % changes
from baseline than the Control Group. Triacylglycerol was significantly higher in Group CHE vs. Control. MDA values
were significantly lower in Group ME vs. Control and CHE. ALT and AST were significantly higher in Group CHE vs.
Control. g-GT was lower in Group ME vs. Control. Aortic intimal thickness was significantly less in Groups ME and
CHE vs. Control; Group ME atherosclerotic lesions were significantly less extensive vs. Groups Control and CHE. Only
Group CHE had significant liver fatty infiltration.
Conclusions: During short-term administration concomitantly with atherogenic diet, both P. vera extracts were
beneficial on HDL-, LDL-cholesterol and aortic intimal thickness. The ME additionally presented an antioxidant
effect and significant decrease of aortic surface lesions. These results indicate that P. vera dietary inclusion, in
particular its ME, is potentially beneficial in atherosclerosis management.
Background
Cardiovascular disease is the leading cause of mortality
in the industrialized part of the world with atherosclero-
sis being its primary manifestation [1]. The development
and progression of atherosclerotic lesions has been stu-
died extensively. Many clinical studies have been per-
formed regarding dietary protocols, such as the Seven
Countries study on Mediterranean diet which includes
olive oil [2]. Other clinical studies have involved phar-
maceutical [3] and surgical interventions alone [4], or in
combination [5]. Scientific evidence for the pathogenesis
and therapy of atherosclerosis during the last century
has derived to a large extent from research protocols on
animal models.
The rabbit, one of the most important models for the
study of atherosclerosis, rapidly responds to the induce-
ment of atherosclerotic lesions through a high choles-
terol diet [6]. Several dietary studies have used this
model, including the administration of olive or fish oil
and different seed extracts or oils, derived from sun-
flower seeds, peanuts, flaxseeds or hazelnuts [7-10]. An
edible nut, consumed either alone or as an ingredient in
traditional recipes, is the pistachio nut from the tree
Pistacia vera,w h i c hb e l o n g st ot h eAnacardiaceae
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Greece, as well as other Mediterranean and Middle East
countries. To our knowledge, only in vitro studies are
published regarding its bioactive effect on the develop-
ment of atherosclerosis [11]. We, therefore, sought to
investigate the effect of P. vera cyclohexane (CHE) and
methanolic extract (ME) administration on the rabbit
experimental model of atherosclerosis on serum bio-
chemistry, as well as aortic, heart and liver lesions.
Results
I nT a b l e1t h ed e s c r i p t i v estatistics of the measured
parameters of the 3 Groups are shown. Table 2 shows
median % changes from baseline of body weight, lipid
profile and antioxidant status biochemical parameters
and the overall statistical significances. Table 3 shows
median % changes from baseline of liver enzymes
activity and the overall statistical significances. Table 4
shows morphometric analysis on rabbit aortas.
Body weight
The final median % change from baseline in Groups
Control, ME and CHE was not statistically significant
(Table 2), although a mild increase in absolute mean
values was observed (Table 1).
Biochemical values
Plasma lipid levels
Plasma lipid levels of all three Groups were similar at
baseline. The median % changes from baseline during
the observation period described below are shown in
Table 2.
TC The median % change from baseline to 1
st month
for Groups ME and CHE was statistically significantly
Table 1 Descriptive statistics: mean values ± standard deviation of body weight and biochemical parameters
Baseline 1
st month 2
nd month 3
rd month
Group Control
WEIGHT (Kg) 3.17 ± 0.21 3.46 ± 0.18 3.54 ± 0.27 3.49 ± 0.19
TC (mg/dL) 67.88 ± 5.66 649.88 ± 44.4 987.13 ± 95.00 1347.00 ± 149.33
HDL-C (mg/dL) 24.62 ± 2.38 62.37 ± 17.20 59.875 ± 20.95 46.37 ± 4.20
LDL-C (mg/dL) 23.72 ± 4.82 555.7 ± 46.54 854.62 ± 83.41 1146.60 ± 159.25
TAG (mg/dL) 97.63 ± 12.93 159 ± 24.96 363.13 ± 26.28 770.13 ± 68.48
MDA (nmol/L) 1.14 ± 0.14 1.74 ± 0.19 2.22 ± 0.16 3.47 ± 0.47
ALT (IU/L) 7.75 ± 2.12 15.37 ± 3.46 24.38 ± 3.30 37.25 ± 5.42
AST (IU/L) 11.75 ± 2.87 33.38 ± 8.30 42.00 ± 6.05 47.75 ± 6.69
gGT (IU/L) 14.25 ± 2.71 47.13 ± 13.42 77.00 ± 15.23 215.13 ± 67.34
Group ME
WEIGHT (Kg) 3.09 ± 0.19 3.24 ± 0.26 3.37 ± 0.15 3.40 ± 0.14
TC (mg/dL) 55.75 ± 11.67 697.63 ± 75.20 881.25 ± 66.00 1130.5 ± 146.07
HDL-C (mg/dL) 19.75 ± 4.65 57.125 ± 23.27 76.875 ± 15.62 57.62 ± 15.26
LDL-C (mg/dL) 23.15 ± 9.16 602.82 ± 84.69 740.52 ± 56.36 958.22 ± 146.61
TAG (mg/dL) 64.25 ± 9.42 188.38 ± 49.20 319.25 ± 38.53 573.25 ± 63.15
MDA (nmol/L) 1.12 ± 0.09 1.99 ± 0.27 2.73 ± 0.33 3.50 ± 0.71
ALT (IU/L) 8.25 ± 2.25 20.88 ± 5.05 33.88 ± 4.97 49.88 ± 4.26
AST (IU/L) 16 ± 13.53 39.38 ± 15.36 49.63 ± 16.63 59.63 ± 13.8
gGT (IU/L) 16.13 ± 3.78 42.5 ± 10.90 127.13 ± 16.37 161.88 ± 66.13
Group CHE
WEIGHT (Kg) 3.17 ± 0.22 3.50 ± 0.27 3.50 ± 0.28 3.52 ± 0.37
TC (mg/dL) 65.87 ± 11.59 670.13 ± 52.56 979.50 ± 173.68 1477.13 ± 190.83
HDL-C (mg/dL) 16.62 ± 4.00 78.75 ± 7.89 87.75 ± 6.60 68.75 ± 17.88
LDL-C (mg/dL) 33.22 ± 11.43 543.62 ± 44.61 807.82 ± 170.22 1234.62 ± 181.51
TAG (mg/dL) 80.13 ± 13.55 238.75 ± 46.40 419.63 ± 46.55 868.75 ± 224.28
MDA (nmol/L) 1.13 ± 0.10 1.97 ± 0.33 2.54 ± 0.41 4.19 ± 1.02
ALT (IU/L) 8.25 ± 4.10 23.00 ± 5.55 36.25 ± 6.54 60.87 ± 17.45
AST (IU/L) 14.00 ± 4.00 46.12 ± 11.09 57.37 ± 17.68 86.00 ± 8.83
gGT (IU/L) 18.50 ± 3.02 43.87 ± 13.44 124.87 ± 12.50 217.37 ± 25.12
Mean values regarding body weight, lipid profile and oxidative stress during the observation period in the three Groups: Control (atherogenic diet),M E
(atherogenic diet plus ME), CHE (atherogenic diet plus CHE).
All variables are presented as mean ± SD
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Page 2 of 9Table 2 Percent changes of body weight, lipid profile and oxidative stress in rabbit serum
Group % change
baseline - 1
st month
% change
baseline - 2
nd month
% change
baseline - 3
rd month
RABBIT WEIGHT (Kg) Control 9.71 12.91 8.99
ME 5.05 9.72 9.47
CHE 7.74 11.80 10.76
Overall Sig NS NS NS
TC (mg/dL) Control 830.55 1351.17 1941.41
ME 1155.48
a 1523.27 2018.04
CHE 865.03
b 1396.17 2330.76
Overall Sig < 0.0005 NS NS
HDL-C (mg/dL) Control 189.74 185.74 81.55
ME 163.33 262.98
a 212.42
a
CHE 344.74
ab 350.00
ab 294.74
a
Overall Sig < 0.0005 < 0.0005 < 0.0005
LDL-C (mg/dL) Control 2124.53 3148.05 4876.60
ME 2355.51 3239.36 4301.47
CHE 1524.47
ab 2403.38
a 4011.39
Overall Sig < 0.0005 < 0.0005 NS
TAG (mg/dL) Control 56.43 275.45 708.35
ME 200.00
a 388.28
a 810.75
CHE 188.18
a 356.43
a 927.84
a
Overall Sig < 0.0005 < 0.0005 < 0.0005
MDA (nmol/L) Control 50.19 91.93 196.37
ME 64.71
a 70.26 160. 51
a
CHE 73.71 146.43
b 297.85
b
Overall Sig < 0.0005 0.032 0.012
Median % change from baseline in body weight, lipid profile and oxidative stress values during the observation period in the three Groups: Control (atherogenic
diet), ME (atherogenic diet plus ME), CHE (atherogenic diet plus CHE).
a Significant difference for p < 0.05, compared to Control Group
b Significant difference for p < 0.05, compared to Group ME
Overall Sig: Overall significance, NS: Non-significant
Table 3 Percent changes of liver enzyme activities in rabbit serum
Group % change
baseline-1
st month
% change
baseline-2
nd month
% change
baseline-3
rd month
ALT (IU/L) Control 105.00 202.14 350.71
ME 163.89 327.22
a 448.89
CHE 198.57
a 429.76
a 648.81
a
Overall Sig 0.002 0.005 0.001
AST (IU/L) Control 167.53 247.08 300.32
ME 268.18 415.15 472.73
CHE 250.77 382.05 569.23
a
Overall Sig NS NS 0.018
gGT (IU/L) Control 231.94 436.90 1345.75
ME 183.59 650.38
a 855.06
a
CHE 123.68
a 561.40
a 1227.86
b
Overall Sig < 0.0005 < 0.0005 < 0.0005
Median liver enzyme activity % change from baseline during the observation period in the three Groups. Control Group: atherogenic diet, Group ME: atherogenic
diet plus ME, Group CHE: atherogenic diet plus CHE
a Significant difference for p < 0.05, compared to Control Group
b Significant difference for p < 0.05, compared to Group ME
Overall Sig: Overall significance, NS: Non-significant
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0.05 respectively).
HDL-C The median % change of Group CHE was statis-
tically significantly higher compared to Groups Control
and ME at the 1
st and 2
nd months, while Groups ME
and CHE had statistically significant higher values than
the Control Group in the 2
nd (p = 0.001 and p < 0.005
respectively) and 3
rd month (p = 0.01, p < 0.005
respectively).
LDL-C The median % change of Group CHE was statis-
tically significantly lower compared to the Control
Group, in the 1
st and 2
nd month (p < 0.005), while the
median % change of Group CHE was statistically signifi-
cantly lower compared to Group ME only in the 1
st
month (p = 0.038).
TAG The median % change of Group ME was statisti-
cally significantly higher compared to the Control
Group in the 1
st and 2
nd month (p < 0.005 and p =
0.001 respectively). The % change of Group CHE values
was significantly higher than those of the Control
Group throughout the study (p < 0.005, p = 0.003 and
p = 0.05 respectively).
Antioxidant evaluation
MDA The median % change of Group CHE was statisti-
cally significantly higher compared to Group ME in the
2
nd and 3
rd month (p = 0.032 and 0.012 respectively).
Moreover the median % change of Group ME was sta-
tistically significantly different compared to the Control
Group in the 1
st and 3
rd month (p < 0.0005 and p =
0.032 respectively).
Liver function
ALT The median % change of Group ME was statisti-
cally significantly higher compared to the Control
Group in the 2
nd month (p = 0.05), while the median %
change of Group CHE compared to the Control Group
was significantly higher throughout the study (p < 0.05).
AST The median % change of plasma values of all
Groups did not show a statistically significant increase
during the whole experimental period with Group CHE
having higher values only in the 3rd month (p = 0.007).
gGT The median % change of Group ME values was sta-
tistically significant lower compared to Groups Control
and CHE in the 3
rd month of the experiment (p < 0.005).
Tissue pathology
Aorta
Aortic macroscopic specimens from Groups Control
and CHE showed extensive atherosclerotic plaques cov-
ering almost the whole upper part of the excised aorta
(Table 4 and Fig. 1A and 1E). Group ME specimens
showed less extensive lesions compared to Group A, as
well as compared to Group CHE (Table 4 and Fig. 1C).
Histopathological findings from Group Control and
CHE showed vulnerable plaques with many foam cells,
inflammation and remarkable intimal thickening (Fig.
1B and 1F). In Group ME the above described lesions,
but less extensive, were detected (Fig. 1D).
Heart and liver
Histological examination of the heart did not reveal
significant changes between Groups.
Histological examination of the liver did not reveal
significant changes between Groups Control and ME.
Group CHE presented statistically significant fatty infil-
tration compared to the Control Group.
Discussion
The non-genetic hyperlipidemic rabbit is an animal
model widely used in atherosclerosis studies. Various
levels of dietary cholesterol (0.2-1.3%) have been used to
create the disease experimentally [12,13] and concomi-
tant administration of other potentially beneficial sub-
stances has been studied for periods varying from 8 [12]
up to 14 weeks [10,12].
The Pistacia plants are trees or bushes indigenous to
Greece and other Mediterranean and Middle East coun-
tries. Among their 11 species, P. lentiscus has been
shown to have antioxidant [14], antibacterial [15,16],
liver-protective [17] and cytostatic [14] effects and to pre-
vent human LDL-cholesterol from oxidation in vitro [18].
P. terebinthus has been demonstrated to have a beneficial
action on uterine condylomata and skin melanomas [14].
Few studies have been carried out on P. vera.I th a sb e e n
reported to have plant antifungal effects [19]. P. vera ME
contains small quantities of catechin, a polyphenolic fla-
vonoid that shows potentially higher antioxidant activity
than ascorbic acid and a- tocopherol in in vitro studies
[20]. Catechin and its products have also been indicated
as factors of reducing cardiovascular risk by lowering
serum cholesterol levels, diminishing platelet aggregation
and reducing blood pressure [21].
In the present study we investigated the effect of the
co-administration of P. vera, on the progress of choles-
terol-induced atherosclerosis of the rabbit animal model
for 12 weeks. We chose to administer the ME or CHE
of P. vera separately in different animal groups, in order
to be able to identify which components would be
responsible for the potentially different results. GC-MS
analysis of the CHE showed that its major compounds
Table 4 Morphometric analysis on rabbit aortas
Group thickness (mm) surface area (mm
2/mm)
Control (n = 8) 0.883 ± 0.199 0.932 ± 0.161
ME (n = 8) 0.152 ± 0.128
a 0.256 ± 0.159
a
CHE (n = 8) 0.468 ± 0.222
ab 0.864 ± 0.205
b
Results are expressed as median ± SD.
Control Group: atherogenic diet, Group ME: atherogenic diet plus ME, Group
CHE: atherogenic diet plus CHE
a Significant difference for p < 0.05, compared to Control Group
b Significant difference for p < 0.05, compared to Group ME
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tic acid. Clinical trials have already shown the protective
effects of such plant sterols in the development of cor-
onary heart disease [22]. Furthermore, analysis of the
ME using LC-HRMS/MS techniques revealed the pre-
sence of gallic methyl ester, protocatechuic acid and gal-
lic acid. Gallic acid has been demonstrated to have
antiatherogenic activity [23].
T h er e s u l t so ft h ep r e s e n ts t u d ys h o wab e n e f i c i a l
effect of the co-administration of the P. vera ME and
CHE in cholesterol enriched diet on HDL-C changes.
ME also demonstrated less MDA change from baseline,
revealing thus a mild antioxidant effect. The LDL-C
beneficial effect of ME was not statistically significant.
The other biochemical parameters examined (TC, TAG
and liver enzymes), did not demonstrate a beneficial
effect of the ME with the analysis of data using %
change median values. The analysis of our data using
mean absolute values showed a statistically significant
protective effect of the ME on the above parameters
Figure 1 Macro- and microscopic images of representative aortas from rabbits of the three Groups. 1A, 1C, 1E are representative images
from the gross aortic specimens belonging to Groups Control, ME and CHE, respectively. Arrows indicate atherosclerotic plaque formations. As
depicted, the Control Group exhibited extensive atherosclerotic plaques covering almost the whole upper part of the excised aorta. Groups ME
and CHE exhibited less extensive lesions compared to Control Group, and between these two groups, Group ME had the least lesion formation.
1B, 1D, 1F are microphotographs from 1A, 1C, 1E respectively (eosin - hematoxylin, original magnification ×100). Figure 1B (of Control Group)
shows a vulnerable plaque with many foam cells, inflammation and remarkable intimal thickening. Figure 1D (Group ME) shows the above
described lesion, but less extensive (intima/media ratio thickness is less than in 1B. Figure 1F (Group CHE) demonstrates aortic endothelium with
evidence of thickening and many foam cells, however the intima/media ratio is less than in 1B. Arrows indicate the width of the endothelium.
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bution of the values, use of the non-parametric analysis
(Kruskal-Wallis and Mann-Whitney tests) was deemed
necessary.
Several plant substances have a beneficial effect on
blood biochemistry of cholesterol-fed rabbits. The olive
oil polyphenol known as hydroxytyrosol increased the
HDL-C levels of atherogenic diet-fed rabbits [13].
Sesame flour had a beneficial effect on the total choles-
terol and triglyceride levels of cholesterol-fed rabbits
[24]. Also, secoisolariciresinol diglucoside (SDG), a plant
lignan isolated from flaxseed when administered to rab-
bits for 8 weeks resulted in a decrease of LDL-C and an
increase in HDL-C and antioxidant activity [9], similarly
to our study. Furthermore, another study in rabbits
using ethanol extract of Hypericum lysimachioides Boiss
var lysimachioides (Guttifera), showed a statistically sig-
nificant decrease of MDA levels, as well as an increase
of HDL-C levels, in agreement with our study [25].
Our results showed that treatment with both extracts
of P. vera induces a mild increase in TC values,
although this is not significantly different from the Con-
trol Group in the second and third month of
administration.
HDL-C median values in the Control Group were
lower at the end of the experiment, whereas the co-
administration of P. vera extracts (Groups ME and
CHE) significantly inhibited this decrease. Considering
that low HDL-C is associated with a higher risk of car-
diovascular disease, it is supported that increased HDL-
C will result in a protective effect against atherosclero-
sis, after prolonged administration of the P. vera
extracts.
Our results showed significant differences in plasma
MDA levels between the ME and the Control Groups.
This suggests that the P. vera ME’s beneficial effect on
some lipids and the aorta may be due to a mild anti-
oxidant effect.
In our study, liver enzyme levels increased reaching
maximum levels the third month in all groups. Specifi-
cally, ALT and AST changes were increased in Groups
ME and CHE compared to Control. Both clinical and
experimental studies have demonstrated that elevated
ALT and AST can be predictive for the development of
atherosclerosis [26,25]. Furthermore, gGT changes of
Group ME were statistically significantly lower in the
third month compared to the Control Group. This is
indicative of a beneficial effect of the P. vera ME and
CHE in the function of the biliary system of athero-
sclerotic animals. In the study by Hakimoglu et al. [25]
liver hydropic and lipid degeneration was decreased in
ethanol extract of Hypericum lysimachoides compared
to that of the rabbits fed only with cholesterol enriched
diet. This finding is similar to ours, where the liver
histology of ME fed rabbits was less affected than the
cholesterol group (Control), although there was no sta-
tistically significant difference. Specifically, the Control
Group rabbits suffered from hepatic damage charac-
terised by steatosis and fibrosis, which was even more
evident in Group CHE.
Macroscopically plaque formation in Group ME was
less extensive compared to Groups Control and CHE.
Similarly to our study, other researchers have observed
that despite increase of serum cholesterol after the
administration of an extract, the pathology results of the
aortic specimens may show an amelioration of the pro-
gress of atherosclerosis [27]. Aguilera et al. [8] found
that virgin olive oil and fish oils reduce the development
of atherosclerotic plaques. Hazelnut oil has also been
shown to reduce atherosclerotic lesions in the aorta of
cholesterol fed rabbits [10]. In addition, the effect of
green tea administration containing epicatechin derived
compounds in rabbits showed a beneficial effect on the
arterial atherosclerotic plaques [28]. This is in agree-
ment with our findings, which indicated a significant
beneficial effect of the P. vera ME on the development
of aortic atherosclerosis. Specifically, Group ME pre-
sented significant inhibition of atherosclerotic plaques
regarding both their thickness and extent within the
aortic lumen. This may be attributed to the major ME
components, such as gallic acid and catechin that may
be responsible for this inhibition process as already indi-
cated [22,28]. On the other hand, Group CHE exhibited
milder atherosclerosis inhibition regarding plaque thick-
ness, which can be attributed to the presence of b-sitos-
terol, squalene, stigmasterol, oleic and palmitic acid, as
similarly shown [29,30].
Group CHE exhibited the lowest antioxidant activity.
This effect can possibly be linked to the extensive but
not so complicated atherosclerotic lesions observed in
Group CHE aortic specimens compared to those of
Groups Control and ME. Group ME, however, exhibited
a much stronger antioxidant activity. The statistically
significant observed antioxidant effect of the ME, evi-
dent by the MDA analysis, concomitantly decreased aor-
tic plaque deposition significantly. On the other hand,
the CHE did not affect the extent of atherosclerotic
lesions. These findings may be attributed to P.v e r aM E
constituents exerting antioxidant activity [11].
Conclusions
In conclusion, during short-term administration conco-
mitantly with atherogenic diet, both P. vera extracts
were beneficial on HDL-, LDL-cholesterol and aortic
intimal thickness. The ME additionally presented an
antioxidant effect and significant decrease of aortic sur-
face lesions. These results indicate that P. vera dietary
inclusion, in particular its ME, may potentially be
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and CHE are being used in vivo for the first time to our
knowledge in the study of atherosclerosis and show a
promising effect regarding its inhibition process. More
research is required before P. vera may be clinically
recommended for dietary inclusion for atherosclerosis
management.
Methods
Animals
Twenty-four conventional male New Zealand White
rabbits (2.7 ± 0.2 Kg), purchased from a Greek approved
commercial breeder, were randomly divided into three
equal groups (Control, ME and CHE) and kept singly in
stainless steel cages with free access to food and tap
water. The animal house conditions consisted of 20 ±
2°C, 60 ± 5% relative humidity, under a 12:12 h light:
dark cycle. The animals were handled according to stan-
dards imposed by the European Directive 86/609/EEC.
The local veterinary authorities and animal ethics com-
mittee approved (License No. K/950) the study. The
Control Group received standard rabbit balanced diet
(chemical composition: total fatty acids 2.5%, cellulose
18.5%, total protein 16.5%, water 13%, ash 11%, calcium
1.4%, lysine 0.6%, methionine-cystine 0.55%, phosphorus
0.55%, sodium 0.25%) enriched with 1% cholesterol
(Dolder, Switzerland) (atherogenic diet), Group ME
received atherogenic diet plus ME (1% v/w) and Group
CHE atherogenic diet plus CHE (5% v/w). Diets were
freshly prepared every three days before use.
Preparation and analysis of the extracts
Cyclohexane Extract of P. vera (CHE)
A quantity of 15 Kg powdered pistachio nuts collected
in the Greek island of Aegina was extracted at room
temperature, first to be defatted with cyclohexane, giving
7.5 Kg of a green oil residue after evaporation of the sol-
vent. The CHE was saponified by the usual procedure
resulting to esterified fatty acids. The fatty acid methy-
lesters of the oils and the unsaponified residue were
analyzed by GC and GC/MS to afford b-sitosterol, squa-
lene, stigmasterol, oleic acid and palmitic acid as major
compounds (see Additional file 1).
Methanolic Extract of P. vera (ME)
After the extraction of powdered pistachio nuts with
cyclohexane, the plant material was further extracted
with dichloromethane giving 1.5 Kg of green oily extract
and then with methanol to give a residue of 500 g after
e v a p o r a t i o no ft h es o l v e n t .Aq u a n t i t yo f4 0 0go ft h e
residue was subjected to XAD-4 resin for sugar removal
and a ME enriched in phenolic compounds was
obtained. In order to describe the chemical profile of
t h ee n r i c h e de x t r a c taL C - D A D - E S I ( - ) - H R M S / M S
method was developed. The analysis was performed
using a UHPLC apparatus connected to the high resolu-
tion hybrid LTQ-Orbitrap Discovery spectrometer. The
phenolic compounds, gallic methyl ester (1), gallic acid
(2), protocatechuic acid (3)c a t e c h i n( 4) and epicatechin
(5) were used as standards for the analysis and the iden-
tification thereof was accomplished by comparing the
retention time, UV-Vis spectrum and high accurate
mass spectra of the peaks in the sample to those of
standard compounds.
In the attached Additional file 1 a detailed analysis of
the extracts’ components is presented.
Blood samplings and biochemical values
All animals were fasted 12 hours prior to blood sam-
pling. They were mildly sedated (ketamine hydrochlor-
ide 12 mg/kg, xylazine 2.5 mg/kg body weight, im) for
the procedure in order to avoid stress impact. Blood
samples from the auricular artery of animals were
placed into Wassermann tubes containing anticoagulant
at 0, 1, 2 and 3 months of the experimental procedure.
Plasma was separated by centrifugation at 3500 rpm for
15 min. Plasma total cholesterol (TC), high-density lipo-
protein cholesterol (HDL-C), low-density lipoprotein
cholesterol (LDL-C), triacylglycerol (TAG) concentra-
tions, serum alanine aminotransferase (ALT), serum
aspartate aminotransferase (AST) and gamma glutamyl
transferase (gGT) activities were measured by commer-
cial enzymatic test kits according to the manufacturer’s
instructions (Biomerieux, Lyon, France) using an auto-
matic analyser (Type 7170A, Hitachi, Tokyo, Japan).
MDA was calculated by the thiobarbituric acid reactive
substances (TBARS) manual method as described by
Yagi [31]. At the end of the experimental study and
after the last blood sampling under sedation, the rabbits
were euthanized with sodium thiopental (30 mg/kg iv).
Tissue samples
The aorta was removed from the aortic arch to the iliac
bifurcation. The tissues adhering to the adventitia were
removed and the aorta was cut longitudinally along the
mid-ventral wall. The aorta was then fixed flatly in 10%
phosphate buffered formalin solution. The luminal sur-
face of each aortic specimen was photographed and the
image was stored electronically. Sections from all speci-
mens were obtained from three standard sites (immedi-
ately distal to the branch of the left subclavian artery, at
the seventh intercostal artery and immediately posterior
to the celiac artery). These samples were embedded in
paraffin blocks and stained with hematoxylin-eosin. The
histopathologic atherosclerotic lesions of the aorta were
classified according to the Stary [32] classification, while
thickness and surface area of atherosclerotic lesions in
the wall of aortae were semiquantified using an auto-
mated image analysis system [33]. In brief, parameters
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Page 7 of 9evaluated were: intimal thickening, foam cell accumula-
tion, mononuclear infiltrates, lipid core and fibrous cap
formation. Digital images were obtained from the slides
by a photomicroscope (Nikon Eclipse 80i, Nikon Corp,
Tokyo, Japan) equipped with a digital camera (Nikon
DS - 2 MW). All the images were transferred to a PC
with the appropriate software (Image ProPlus v. 5.1,
Media Cybernetics, MD, USA).
T h eh e a r ta n dl i v e rw e r ew e i g h e da n df i x e di n1 0 %
phosphate buffered formalin solution. Standard sections
were taken, embedded in paraffin blocks for hematoxy-
lin-eosin, and the myocardium specimens were addition-
ally stained with Masson’s trichrome stain.
Myocardial lesions were graded from 0 to 3 regarding
interstitial edema, fibrosis and foam cell infiltrates. Liver
lesions were classified in four grades as previously
described [34], regarding alterations of architecture, fatty
infiltration and fibrosis.
Data analyses
Data was expressed as mean values ± standard deviation
(SD) as well as median values because of violation of
normality. The Kolmogorov-Smirnov test was utilized
for normality analysis of the parameters.
To indicate the trend in the first 3 months of treat-
ments the median percentage changes after 1, 2 and 3
months of variables respectively were calculated. Com-
parison of percentage change from baseline of variables
during the observation period and the histopathology
variables between the three groups were analyzed using
the Kruskal-Wallis test and Mann-Whitney test (pair-
wise comparisons).
All tests were two-sided, statistical significance was set
at p < 0.05. All analyses were carried out using the sta-
tistical package SPSS vr 16.00 (Statistical Package for
the Social Sciences, SPSS Inc., Chicago, Ill., USA).
Additional material
Additional file 1: Preparation methods of the cyclohexane and
methanolic extracts. Details regarding the methodology of preparation
of the cyclohexane and methanolic extracts, including 2 figures.
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P.vera: Pistacia vera; ME: methanolic extract of Pistacia vera; CHE: cyclohexane
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Chromatography; DAD: Diode Array Detector; ESI: Electron Spray Ionization;
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Statistical Package for the Social Sciences; SDG: secoisolariciresinol
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